PEACE OKORIE
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner GREENBELT, MD NPI 1124382767
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner MD Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$5,060.02
- Category: General Payments
- Program years: PY2021–2024
- Record count: 189
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,393.52 across 52 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,343.53 | 51 |
| Education | $49.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $253.04 | 6 |
| PFIZER INC. | $100.59 | 4 |
| Gilead Sciences, Inc. | $79.04 | 3 |
| Daiichi Sankyo Inc. | $75.73 | 3 |
| Merck Sharp & Dohme Corporation | $74.92 | 3 |
| GlaxoSmithKline, LLC. | $73.91 | 3 |
| Alexion Pharmaceuticals, Inc. | $58.53 | 2 |
| TAIHO ONCOLOGY, INC. | $57.74 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $57.28 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $54.94 | 2 |
| Lilly USA, LLC | $51.55 | 2 |
| Incyte Corporation | $48.33 | 2 |
| Genentech USA, Inc. | $43.66 | 2 |
| PharmaEssentia USA Corporation | $33.07 | 1 |
| Regeneron Healthcare Solutions, Inc. | $30.62 | 1 |
| Astellas Pharma US Inc | $28.56 | 1 |
| ABBVIE INC. | $26.64 | 1 |
| BeiGene USA, Inc. | $26.10 | 1 |
| Rigel Pharmaceuticals, Inc. | $25.82 | 1 |
| MorphoSys, US Inc. | $24.63 | 1 |
| Mirati Therapeutics, Inc. | $24.31 | 1 |
| EISAI INC. | $23.42 | 1 |
| Acerta Pharma LLC | $22.69 | 1 |
| Organon LLC | $22.30 | 1 |
| Acrotech Biopharma Inc. | $21.65 | 1 |
| Spectrum Pharmaceuticals Inc. | $20.14 | 1 |
| Alnylam Pharmaceuticals Inc. | $17.17 | 1 |
| Coherus Biosciences Inc. | $17.14 | 1 |
By program year
Records — PY2024 (52)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.